You’re grinding through a renal pharm question, you see acetazolamide, and you think: “Cool—proximal tubule, bicarb wasting, metabolic acidosis.” Then the vignette hits you with kidney stones, a funky urine pH, and distractors that all feel kind of right. This is where Q-bank mastery lives: not just picking the correct drug, but knowing why every other option is wrong—fast.
Tag: Renal > Renal Pharmacology & Stones
The Vignette (Q-bank style)
A 28-year-old woman starts a new medication for idiopathic intracranial hypertension. A few weeks later, she develops flank pain and hematuria. Urinalysis shows an alkaline urine pH. Serum labs reveal a normal anion gap metabolic acidosis.
Which medication is most likely responsible?
A. Furosemide
B. Hydrochlorothiazide
C. Acetazolamide
D. Spironolactone
E. Amiloride
The Correct Answer: C. Acetazolamide
Why it fits the vignette
Carbonic anhydrase inhibitors (CAIs) (e.g., acetazolamide, methazolamide) inhibit carbonic anhydrase in the proximal convoluted tubule (PCT).
Key physiologic effect
Carbonic anhydrase is required for reclaiming filtered bicarbonate. Block it → bicarbonate stays in the tubular lumen → you pee out bicarbonate.
- Urine pH increases (more in urine → alkaline urine)
- Serum decreases → metabolic acidosis
- Because you’re losing bicarbonate (not accumulating an organic acid), it’s a normal anion gap (hyperchloremic) metabolic acidosis
Why stones?
CAIs predispose to calcium phosphate stones due to:
- Alkaline urine → decreases solubility of calcium phosphate (stone risk goes up as urine pH rises)
- Hypocitraturia: metabolic acidosis increases proximal citrate reabsorption → less citrate in urine, and citrate normally binds calcium to keep it soluble
High-yield: Alkaline urine → favors calcium phosphate and struvite stones, while acidic urine favors uric acid and cystine stones.
Carbonic Anhydrase Inhibitors: What USMLE Loves
Mechanism (one-liner)
Inhibit carbonic anhydrase in PCT → ↓ secretion + ↓ reabsorption → alkaline urine + metabolic acidosis
Expected lab pattern
| Finding | Direction | Why |
|---|---|---|
| Serum | ↓ | bicarb wasting |
| Serum pH | ↓ | metabolic acidosis |
| Anion gap | Normal | hyperchloremic acidosis |
| Urine pH | ↑ | bicarbonaturia |
| Serum | ↓ (often) | increased distal Na delivery → more K secretion |
Classic indications
- Idiopathic intracranial hypertension (pseudotumor cerebri) (↓ CSF production)
- Glaucoma (↓ aqueous humor production)
- Acute mountain sickness (induces metabolic acidosis → ↑ ventilatory drive)
- Metabolic alkalosis (especially diuretic-induced)
Adverse effects to memorize
- “Causes Acidosis” (metabolic acidosis)
- Renal stones (calcium phosphate)
- Hypokalemia
- Paresthesias
- Sulfonamide allergy (acetazolamide is a sulfonamide derivative)
- Can worsen hepatic encephalopathy (alkalinizes urine → ↓ trapping; plus systemic changes may increase ammonia availability)
Now: Why Every Distractor Is Wrong (and what it would cause)
A. Furosemide (Loop diuretic)
Why it’s tempting: diuretic → electrolytes → stones?
Why it’s wrong: loop diuretics cause metabolic alkalosis and increase urinary calcium excretion, but they do not alkalinize urine in the characteristic “bicarb-wasting” way of CAIs.
Loop high-yields:
- Site: NKCC2 in thick ascending limb
- Labs: hypokalemic metabolic alkalosis
- Calcium: hypercalciuria → can contribute to stones, but classic association is nephrolithiasis risk + ototoxicity in certain contexts
- Also: ↑ Mg excretion
What you’d expect instead of the vignette:
- Metabolic alkalosis (not NAGMA)
- Urine pH is not the classic teaching hook
B. Hydrochlorothiazide (Thiazide diuretic)
Why it’s tempting: thiazides are tied to calcium and stones.
Why it’s wrong: thiazides decrease urinary calcium—they’re used to prevent calcium stones, not cause them.
Thiazide high-yields:
- Site: Na/Cl cotransporter in distal convoluted tubule
- Labs: hypokalemic metabolic alkalosis
- Calcium: hypocalciuria (↑ Ca reabsorption)
- Side effects: hyperGLUC (hyperglycemia, hyperlipidemia, hyperuricemia, hypercalcemia)
What you’d expect:
- Possibly fewer calcium oxalate stones over time
- No signature alkaline urine + NAGMA combo
D. Spironolactone (K-sparing; aldosterone antagonist)
Why it’s tempting: potassium-sparing diuretics affect acid-base.
Why it’s wrong: spironolactone can cause metabolic acidosis, but via a different mechanism (type 4 RTA physiology) and it does not classically cause alkaline urine + calcium phosphate stones.
Spironolactone high-yields:
- Site: collecting duct (principal cells)
- Effect: ↓ ENaC-mediated Na reabsorption indirectly by blocking aldosterone → ↓ K and H secretion
- Labs: hyperkalemia + mild metabolic acidosis
- Endocrine side effects: gynecomastia, impotence, menstrual irregularities (antiandrogen effects)
Clue mismatch: your vignette hints at alkaline urine and stone type linked to high urine pH—that’s a CAI pattern, not aldosterone blockade.
E. Amiloride (K-sparing; ENaC blocker)
Why it’s tempting: also K-sparing; also affects acid-base.
Why it’s wrong: amiloride can cause hyperkalemia and mild metabolic acidosis (again, type 4-ish physiology), but not the hallmark bicarbonaturia → alkaline urine you see with CAIs.
Amiloride high-yields:
- Site: ENaC blocker in collecting duct
- Special use: Liddle syndrome (also triamterene)
- Labs: hyperkalemia, possible metabolic acidosis
Clue mismatch: kidney stones + alkaline urine after treatment for IIH screams acetazolamide.
Stone Chemistry: Quick Rule Set for Exams
Urine pH matters
| Urine pH | Stone types favored | Classic associations |
|---|---|---|
| Acidic | Uric acid, cystine | gout, tumor lysis; cystinuria (COLA transporter defect) |
| Alkaline | Calcium phosphate, struvite | CA inhibitors / distal RTA; urease+ organisms |
CA inhibitors vs distal (type 1) RTA—don’t mix them up
Both can cause calcium phosphate stones and alkaline urine, but the “why” differs:
- Acetazolamide: proximal effect → bicarbonate wasting → alkaline urine + NAGMA
- Distal (type 1) RTA: impaired distal secretion → urine can’t acidify → alkaline urine + NAGMA + stones
If a stem highlights a new drug for glaucoma/IIH/mountain sickness, go acetazolamide. If it highlights autoimmune disease (e.g., Sjögren) or amphotericin B, think type 1 RTA.
Rapid-Fire Test-Day Takeaways
- Acetazolamide → alkaline urine + NAGMA + calcium phosphate stones
- CAIs treat: glaucoma, IIH, acute mountain sickness, metabolic alkalosis
- Thiazides prevent calcium stones (↓ urinary Ca)
- Loop diuretics cause hypercalciuria but typically metabolic alkalosis, not CAI’s signature pattern
- K-sparing diuretics → hyperkalemia (a quick way to eliminate choices if the stem shows low K)